Stevard LLC’s Gilead Sciences GILD Stock Holding History

Stevard LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,900	Closed	-$562K	–	103
2020 Q3	$562K	Buy	8,900 +1,648	+23%	+$114K	0.23%	63
2020 Q2	$558K	Buy	+7,252	New	+$556K	0.29%	54

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stevard LLC's GILD Position: Q4 2020 in Review

Stevard LLC sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 8,900 shares — an estimated $562K sold.

Stevard LLC first reported a position in GILD in Q2 2020 and held it in 2 quarters. The position peaked at $562K in Q3 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Stevard LLC reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Stevard LLC sold 8,900 Gilead Sciences shares in Q4 2020, an estimated $562K.
Stevard LLC first reported a position in Gilead Sciences in Q2 2020 and held it in 2 quarters.
Stevard LLC's Gilead Sciences position peaked at $562K in Q3 2020.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Stevard LLC's 13F filing for Q4 2020, filed 12 Feb 2021.